We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

woensdag 26 juli 2017

British Journal of Cancer - Table of Contents alert Volume 117 Issue 3

If you are unable to see the message below, click here to view.
British Journal of Cancer

TABLE OF CONTENTS

Volume 117, Issue 3 (301-449)
Published online 25 July 2017

In this issue
Minireview
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics & Genomics
Epidemiology

Also new today
Advance online publication
Digital Edition
Sign up for e-alerts Follow BJC on Twitter Follow us on Twitter

Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Minireview

Top

Mitochondria on the move: emerging paradigms of organelle trafficking in tumour plasticity and metastasis

Dario C Altieri

Br J Cancer 2017 117: 301-305; advance online publication, July 4, 2017; 10.1038/bjc.2017.201

Abstract | Full Text

Clinical Studies

Top

Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors

Anna M van Eggermond, Michael Schaapveld, Cécile PM Janus, Jan Paul de Boer, Augustinus DG Krol, Josée M Zijlstra, Richard WM van der Maazen, Leontien C Kremer, Monique E van Leerdam, Marieke WJ Louwman, Otto Visser, Marie L De Bruin, Berthe MP Aleman and Flora E van Leeuwen

Br J Cancer 2017 117: 306-314; advance online publication, June 20, 2017; 10.1038/bjc.2017.177

Abstract | Full Text

The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab

Laura Demurtas, Marco Puzzoni, Riccardo Giampieri, Pina Ziranu, Valeria Pusceddu, Alessandra Mandolesi, Chiara Cremolini, Gianluca Masi, Fabio Gelsomino, Carlotta Antoniotti, Cristian Loretelli, Fausto Meriggi, Alberto Zaniboni, Alfredo Falcone, Stefano Cascinu and Mario Scartozzi

Br J Cancer 2017 117: 315-321; advance online publication, June 20, 2017; 10.1038/bjc.2017.178

Abstract | Full Text

No additional prognostic value for MRE11 in squamous cell carcinomas of the anus treated with chemo-radiotherapy

Alexandra K Walker, Christiana Kartsonaki, Elena Collantes, Judith Nicholson, Duncan C Gilbert and Anne E Kiltie

Br J Cancer 2017 117: 322-325; advance online publication, June 22, 2017; 10.1038/bjc.2017.188

Abstract | Full Text

Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: a multicenter study

A Y Zhang, I Judson, C Benson, J S Wunder, I Ray-Coquard, R J Grimer, R Quek, E Wong, A B Miah, P C Ferguson, A Dufresne, J Y H Teh, M Stockler and M H N Tattersall

Br J Cancer 2017 117: 326-331; advance online publication, June 27, 2017; 10.1038/bjc.2017.198

Abstract | Full Text

Translational Therapeutics

Top

Embracing model-based designs for dose-finding trials

Sharon B Love, Sarah Brown, Christopher J Weir, Chris Harbron, Christina Yap, Birgit Gaschler-Markefski, James Matcham, Louise Caffrey, Christopher McKevitt, Sally Clive, Charlie Craddock, James Spicer and Victoria Cornelius

Br J Cancer 2017 117: 332-339; advance online publication, June 29, 2017; 10.1038/bjc.2017.186

Abstract | Full Text

Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma

Bruno Vincenzi, Silvia Stacchiotti, Paola Collini, Francesco Pantano, Carla Rabitti, Giuseppe Perrone, Michele Iuliani, Alfonso Baldi, Giuseppe Badalamenti, Roberta Sanfilippo, Daniele Santini, Andrea Onetti Muda, Alessandro Gronchi, Paolo Casali, Angelo Paolo Dei Tos and Giuseppe Tonini

Br J Cancer 2017 117: 340-346; advance online publication, June 22, 2017; 10.1038/bjc.2017.187

Abstract | Full Text

Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer

Daniele Oddo, Giulia Siravegna, Annunziata Gloghini, Claudio Vernieri, Benedetta Mussolin, Federica Morano, Giovanni Crisafulli, Rosa Berenato, Giorgio Corti, Chiara Costanza Volpi, Michela Buscarino, Monica Niger, Philip D Dunne, Giuseppe Rospo, Emanuele Valtorta, Alice Bartolini, Giovanni Fucà, Simona Lamba, Antonia Martinetti, Maria Di Bartolomeo, Filippo de Braud, Alberto Bardelli, Filippo Pietrantonio and Federica Di Nicolantonio

Br J Cancer 2017 117: 347-352; advance online publication, June 27, 2017; 10.1038/bjc.2017.196

Abstract | Full Text

Molecular Diagnostics

Top

Characterisation of blood-derived exosomal hTERT mRNA secretion in cancer patients: a potential pan-cancer marker

Hadar Goldvaser, Anna Gutkin, Einat Beery, Yonatan Edel, Jardena Nordenberg, Ofir Wolach, Ester Rabizadeh, Orit Uziel and Meir Lahav

Br J Cancer 2017 117: 353-357; advance online publication, June 22, 2017; 10.1038/bjc.2017.166

Abstract | Full Text

Extreme assay sensitivity in molecular diagnostics further unveils intratumour heterogeneity in metastatic colorectal cancer as well as artifactual low-frequency mutations in the KRAS gene

Sara Mariani, Luca Bertero, Simona Osella-Abate, Cristiana Di Bello, Paola Francia di Celle, Vittoria Coppola, Anna Sapino, Paola Cassoni and Caterina Marchiò

Br J Cancer 2017 117: 358-366; advance online publication, June 15, 2017; 10.1038/bjc.2017.170

Abstract | Full Text

Tumour heterogeneity poses a significant challenge to cancer biomarker research

Karolina Cyll, Elin Ersvær, Ljiljana Vlatkovic, Manohar Pradhan, Wanja Kildal, Marte Avranden Kjær, Andreas Kleppe, Tarjei S Hveem, Birgitte Carlsen, Silje Gill, Sven Löffeler, Erik Skaaheim Haug, Håkon Wæhre, Prasanna Sooriakumaran and Håvard E Danielsen

Br J Cancer 2017 117: 367-375; advance online publication, June 15, 2017; 10.1038/bjc.2017.171

Abstract | Full Text

Oral squamous cell carcinoma patients can be differentiated from healthy individuals with label-free serum proteomics

Mayank Saraswat, Antti Mäkitie, Rahul Agarwal, Sakari Joenväärä and Suvi Renkonen

Br J Cancer 2017 117: 376-384; advance online publication, June 20, 2017; 10.1038/bjc.2017.172

Abstract | Full Text

CD47 overexpression is associated with decreased neutrophil apoptosis/phagocytosis and poor prognosis in non-small-cell lung cancer patients

Lourdes Barrera, Edgar Montes-Servín, Juan-Manuel Hernandez-Martinez, María de los Ángeles García-Vicente, Elizabeth Montes-Servín, Marytere Herrera-Martínez, José C Crispín, José Rafael Borbolla-Escoboza and Oscar Arrieta

Br J Cancer 2017 117: 385-397; advance online publication, June 20, 2017; 10.1038/bjc.2017.173

Abstract | Full Text

Post-translational regulation contributes to the loss of LKB1 expression through SIRT1 deacetylase in osteosarcomas

Nadège Presneau, Laure Alice Duhamel, Hongtao Ye, Roberto Tirabosco, Adrienne M Flanagan and Malihe Eskandarpour

Br J Cancer 2017 117: 398-408; advance online publication, June 20, 2017; 10.1038/bjc.2017.174

Abstract | Full Text

Genetics & Genomics

Top

Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer

Yusuke Goto, Akira Kurozumi, Takayuki Arai, Nijiro Nohata, Satoko Kojima, Atsushi Okato, Mayuko Kato, Kazuto Yamazaki, Yasuo Ishida, Yukio Naya, Tomohiko Ichikawa and Naohiko Seki

Br J Cancer 2017 117: 409-420; advance online publication, June 22, 2017; 10.1038/bjc.2017.191

Abstract | Full Text

Comprehensive analysis of copy number aberrations in microsatellite stable colon cancer in view of stromal component

M Henar Alonso, Susanna Aussó, Adriana Lopez-Doriga, David Cordero, Elisabet Guinó, Xavier Solé, Mercè Barenys, Javier de Oca, Gabriel Capella, Ramón Salazar, Rebeca Sanz-Pamplona and Victor Moreno

Br J Cancer 2017 117: 421-431; advance online publication, July 6, 2017; 10.1038/bjc.2017.208

Abstract | Full Text

Epidemiology

Top

Commonly used medications and endometrial cancer survival: a population-based cohort study

Omolara B Sanni, Úna C Mc Menamin, Chris R Cardwell, Linda Sharp, Liam J Murray and Helen G Coleman

Br J Cancer 2017 117: 432-438; advance online publication, July 6, 2017; 10.1038/bjc.2017.207

Abstract | Full Text

A cancer geography paradox? Poorer cancer outcomes with longer travelling times to healthcare facilities despite prompter diagnosis and treatment: a data-linkage study

Melanie Turner, Shona Fielding, Yuhan Ong, Chris Dibben, Zhiqianq Feng, David H Brewster, Corri Black, Amanda Lee and Peter Murchie

Br J Cancer 2017 117: 439-449; advance online publication, June 22, 2017; 10.1038/bjc.2017.180

Abstract | Full Text

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature